Quantcast

Latest International AIDS Vaccine Initiative Stories

2010-10-01 06:30:00

ATLANTA, Oct. 1 /PRNewswire/ -- Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, presented the results of a study using granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjuvant for the GeoVax DNA/MVA vaccine at the AIDS Vaccine 2010 conference held in Atlanta from September 28 to October 1. The talk, given on Thursday, September 30 in...

2010-09-30 20:12:56

As researchers and policymakers work toward an effective HIV vaccine in a constrained global economy, cost-effective prevention strategies such as Couples Voluntary Counseling and Testing (CVCT) must take a larger role in efforts to decrease the rates of HIV/AIDS in Africa, says Emory University HIV/AIDS vaccine researcher Susan Allen, MD, MPH. Allen, who has worked to combat the AIDS epidemic in Africa for more than 25 years, highlighted the value of CVCT and other cost-effective HIV...

2010-09-27 06:30:00

ATLANTA, Sept. 27 /PRNewswire/ -- Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, will present the results of a study using granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjuvant for the GeoVax DNA/MVA vaccine at the AIDS Vaccine 2010 conference to be held in Atlanta from September 28 to October 1. The talk, to be given on Thursday,...

2010-09-07 18:03:00

NEW YORK, Sept. 7 /PRNewswire-USNewswire/ -- AVAC welcomes the new Global HIV Vaccine Enterprise Scientific Strategic Plan, released today, as a critical document that the field must implement as part of ongoing efforts to improve coordination, efficiency and transparency to quickly capitalize on recent advances in AIDS vaccine research. The Plan comes at a crucial time in the field. In the last year, the RV144 Thai vaccine trial proved that an AIDS vaccine is possible, which along with...

2010-09-07 06:30:00

ATLANTA, Sept. 7 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announces that Chief Executive Officer Dr. Robert McNally will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference. The presentation is currently scheduled for 12:30 PM, September 14, 2010, in the Winslow Salon, 5th Floor of the New York Palace Hotel in New York City. Dr. McNally said, "The Rodman and...

2010-08-27 07:00:00

ATLANTA, Aug. 27 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, today announced the results of its Annual Shareholders Meeting, held on August 24, 2010. During the meeting, shareholders re-elected seven nominees for directors of the company to serve until the 2011 Annual Meeting of Shareholders and until their successors are duly elected or appointed and qualified. They are:...

2010-08-17 07:00:00

ROCKVILLE, Md., Aug. 17 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the IMVAC Summit. The Conference will take place August 17-19, 2010 at the Royal Sonesta Hotel, Cambridge, MA. Dr. Steven Pincus will be presenting, "Influenza Virus-Like Particle Vaccine Produced in Insect Cells Elicits Hemagglutination and Neuraminidase Inhibiting Antibodies in Immunized Health Adults," on Tuesday, August...

2010-08-16 07:45:00

Black Treatment Advocates Network (BTAN) Focuses on Improving Care for Thousands of Black Americans in the U.S. WHITEHOUSE STATION, N.J. and LOS ANGELES, Calif., Aug. 16 /PRNewswire-USNewswire/ -- The Black AIDS Institute (The Institute), with support from Merck, announced the launch of the Black Treatment Advocates Network (BTAN). BTAN, the first collaborative Network of its kind, will train and mobilize a team of treatment advocates with a mission to link Black Americans with HIV into...

2010-08-11 11:39:00

ATLANTA, Aug. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announces that Chief Executive Officer Dr. Robert McNally and Chief Financial Officer Mark Reynolds will be presenting at the 2010 Southern California Investor Conference on Tuesday, August 17. The GeoVax presentation will take place at 3:00 pm at The Island Hotel in Newport Beach, California. Hosted by California...

2010-07-22 11:22:00

SMYRNA, Ga., July 22 /PRNewswire-FirstCall/ -- Dr. Harriet L. Robinson, Chief Scientific Officer at GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, discussed the Company's pursuit of a vaccine during a July 20 interview on HealthRadio.net, the leading online talk radio portal devoted to health and medical issues. Dr. Robinson told her interviewer, Dr. Derrick DeSilva, that medical science is further ahead...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related